Related Experiment Video
Updated: Feb 15, 2026

Protocols for Implementing an Escherichia coli Based TX-TL Cell-Free Expression System for Synthetic Biology
Published on: September 16, 2013
Synthetic Biology: Immunotherapy by Design
Jamie Brenner1, Jang Hwan Cho1, Nicole M L Wong1
1Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts 02215, USA;
Abstract:
Cellular immunotherapy holds great promise for the treatment of human disease. Clinical evidence suggests that T cell immunotherapies have the potential to combat cancers that evade traditional immunotherapy. Despite promising results, adverse effects leading to fatalities have left scientists seeking tighter control over these therapies, which is reflected in the growing body of synthetic biology literature focused on developing tightly controlled, context-independent parts. In addition, researchers are adapting these tools for other uses, such as for the treatment of autoimmune disease, HIV infection, and fungal interactions. We review this body of work and devote special attention to approaches that may lend themselves to the development of an "ideal" therapy: one that is safe, efficient, and easy to manufacture. We conclude with a look toward the future of immunotherapy: how synthetic biology can shift the paradigm from the treatment of disease to a focus on wellness and human health as a whole.
Insights
Synthetic biology enhances cellular immunotherapies for safer, more effective treatments against cancer and autoimmune diseases. Future applications aim to shift focus from disease treatment to overall human wellness.
Area of Science:
- Biotechnology and Biomedical Engineering
- Immunology and Cancer Research
- Synthetic Biology Applications
Background:
- Cellular immunotherapy shows promise for treating human diseases, particularly cancers resistant to traditional treatments.
- Adverse effects and fatalities necessitate improved control over T cell immunotherapies.
- Growing synthetic biology research focuses on developing controllable, context-independent biological parts.
Purpose of the Study:
- To review advancements in synthetic biology for enhancing cellular immunotherapies.
- To identify approaches for developing an ideal therapy that is safe, efficient, and easily manufactured.
- To explore the potential of synthetic biology in treating autoimmune diseases, HIV, and fungal infections.
Main Methods:
- Review of existing scientific literature on synthetic biology tools and cellular immunotherapy.
- Analysis of approaches for creating tightly controlled, context-independent biological parts.
- Evaluation of methods for improving safety, efficiency, and manufacturability of immunotherapies.
Main Results:
- Synthetic biology offers tools to enhance control and safety of cellular immunotherapies.
- Researchers are adapting these tools for diverse applications beyond cancer treatment.
- Progress is being made towards developing safer and more efficient therapeutic strategies.
Conclusions:
- Synthetic biology is crucial for overcoming limitations in current immunotherapies.
- The development of an ideal, safe, and efficient therapy is a key goal.
- Synthetic biology can potentially shift healthcare towards a wellness-focused paradigm.
More Related Videos
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Tumor Immunotherapy
Group Design
What is Conservation Biology?
Synthetic Disvision of Polynomials
Factorial Design

